Cargando…
Using serum placenta growth factor could improve the sensitivity of colorectal cancer screening in fecal occult blood negative population: A multicenter with independent cohort validation study
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide. Screening for CRC using the fecal occult blood test (FOBT) is feasible and useful for decreasing disease‐related mortality; however, its sensitivity and compliance are unsatisfactory. METHODS: This study examined the ef...
Autores principales: | Wei, Shu‐Chen, Tsao, Po‐Nien, Wang, Yu‐Ting, Lin, Been‐Ren, Wu, Deng‐Chyang, Tsai, Wen‐Sy, Chen, Jinn‐Shiun, Wong, Jau‐Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601572/ https://www.ncbi.nlm.nih.gov/pubmed/31063258 http://dx.doi.org/10.1002/cam4.2216 |
Ejemplares similares
-
Fecal occult blood test screening uptake among immigrants from Muslim majority countries: A retrospective cohort study in Ontario, Canada
por: Vahabi, Mandana, et al.
Publicado: (2019) -
Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study
por: Hansen, Anette Tarp, et al.
Publicado: (2018) -
Risk of cancer in patients with fecal incontinence
por: Adelborg, Kasper, et al.
Publicado: (2019) -
Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
por: Nielson, Carrie M., et al.
Publicado: (2018) -
Health‐related quality of life of esophageal cancer patients in daily life after treatment: A multicenter cross‐sectional study in China
por: Liu, Qian, et al.
Publicado: (2018)